Thymosin Alpha 1 (Ta1) is a naturally occurring 28-amino acid peptide isolated from the thymus. Known for its powerful immune-modulating properties, Ta1 has been used in the treatment of various immune-related disorders, infections, and cancer. It plays a crucial role in restoring and enhancing immune function, making it particularly beneficial for individuals with compromised immune…
Know More
IV FUNGIN(Micafungin sodium) is a sterile, lyophilized intravenous (IV) infusion. Micafungin sodium is a semisynthetic lipopeptide (echinocandin) synthesized by a chemical modification of a fermentation product of Coleophoma empetri F-11899. Micafungin inhibits the synthesis of 1, 3-β-D-glucan, an integral component of the fungal cell wall. Intravenous micafungin an echinocandin, is approved in the EU for …
Know More
K-Stall is used to help remove excessive amounts of potassium from the blood. K-Stall contains calcium polystyrene sulfonate which contains calcium atoms. This calcium is swapped for potassium in the body, particularly in the large intestine. K-Stall acts by a cumulative process throughout the gastrointestinal tract, removing potassium ions which are excreted in the feces.…
Know More
Ketoalfa contains all amino acids essential for uremic patients, prescribed as treatment of chronic kidney disease patients on conservative management therapy (CKD stage I, II, III). Ketoanalogues maintains the nitrogen levels and tend to serve as one of the nutrient for CKD patients. In combination with very low protein diet/ low protein diet, the medication…
Know More
KETOALFA-DS is 1st time in India tablet which comes in a strength of two conventional alpha ketoanalogues tablet to reduce the increased pill burden in CKD patients and improve their adherence to therapy. It contains all amino acids essential for uremic patients, prescribed as treatment of chronic kidney disease patients on conservative management therapy (CKD…
Know More
Levialfa (Levetiracetam) is a drug within the pyrrolidine class that is used to treat various types of seizures originates from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs). It possesses a wide therapeutic index and little-to-no potential to…
Know More
